Long Road Investment Counsel LLC Buys 699 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Long Road Investment Counsel LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 12.0% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,543 shares of the company’s stock after acquiring an additional 699 shares during the period. Long Road Investment Counsel LLC’s holdings in GE HealthCare Technologies were worth $510,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the stock. Pathway Financial Advisers LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $25,000. BNP Paribas bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $30,000. Rise Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 241.4% during the 1st quarter. Rise Advisors LLC now owns 338 shares of the company’s stock valued at $31,000 after buying an additional 239 shares in the last quarter. Riverview Trust Co bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $31,000. Finally, Elkhorn Partners Limited Partnership bought a new stake in shares of GE HealthCare Technologies during the 2nd quarter valued at $31,000. Institutional investors own 82.06% of the company’s stock.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now directly owns 17,509 shares in the company, valued at approximately $1,414,377.02. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.27% of the stock is currently owned by corporate insiders.

GE HealthCare Technologies Trading Down 0.4 %

GE HealthCare Technologies stock opened at $90.28 on Friday. The business has a 50-day simple moving average of $84.06 and a two-hundred day simple moving average of $83.28. The company has a market cap of $41.21 billion, a P/E ratio of 26.40, a P/E/G ratio of 3.26 and a beta of 1.17. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50. The company has a quick ratio of 0.82, a current ratio of 1.06 and a debt-to-equity ratio of 1.05.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The business’s quarterly revenue was up .5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.92 EPS. Analysts predict that GE HealthCare Technologies Inc. will post 4.26 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a dividend of $0.03 per share. The ex-dividend date is Friday, October 18th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.13%. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.51%.

Analyst Ratings Changes

A number of analysts have recently commented on GEHC shares. Stifel Nicolaus started coverage on shares of GE HealthCare Technologies in a report on Tuesday, August 6th. They set a “buy” rating and a $100.00 target price on the stock. Redburn Atlantic raised GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price target for the company. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research report on Monday, September 9th. They issued a “neutral” rating and a $90.00 price target for the company. Finally, BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a research report on Wednesday. Six equities research analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $95.00.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.